Neurotech International Limited announced that it has appointed a new Scientific Advisory Board (SAB) to help guide the Company's ongoing research and development activities and has promoted Dr. Emanuela Russo to Chief Scientific Officer. Dr. Russo has been the head of research at Neurotech since 2016 and is a cognitive neuroscientist and a clinical psychologist. In her new role as Chief Scientific Officer, she will oversee scientific activities, coordinate research and clinical studies relevant to the development and scientific basis of Mente Autism, as well as contribute to the SAB. As such, the members of the SAB are: Dr. David S. Cantor, who continues his role as Chairman of the SAB; Dr. Emanuela Russo; Dr. Tanju Surmeli; and Dr. Evian Gordon. Dr. David Cantor is a Fellow with the American College of Forensic Examiners, National Academy of Neuropsychology, and the Academy of Learning and Developmental Disorders. He is also Former President of the EEG and Clinical Neuroscience Society and has also been accepted for special fellowships including Congressional Fellow of the American Psychological Association and the State of New York Intercampus Fellow in the area of brain research. More recently, Dr. Cantor has been named as president-elect of the International Society for Neurofeedback and Research (ISNR). Dr. Emanuela Russo joined Neurotech in 2016 as Head of Scientific and Clinical Research. Prior to that, she was Adjunct Professor "Niccolò Cusano" University of Rome. Her research interests regarding the brain correlates of attention and perception as well as the neural patterns underpinning cognitive-emotional states. She is specialized in the brain activity and its utilization as a clinical investigational tool for the evaluation of brain dysfunction. She is focused in the identification of biomarkers within broad categories of disorders (anxiety disorders, depression, ADHD, ASD) and how these indices can be remarkable in the prediction of treatment outcomes and in the development of neuromodulation interventions. Dr. Tanju Surmeli is a board and ECFM certified psychiatrist. His associate professorship application is under reviewal by the Turkish Higher Education Board's appointed jury for works reviewal. In 2001, he founded the Healthy Living Polyclinic and is also the founder of the Biofeedback, Neurofeedback and QEEG/ERP use in Psychiatry Foundation. He is the only BCIAC-EEG certified psychiatrist in Turkey. Dr. Evian Gordon is the Executive Chairman of Brain Resource. He established an "Integrative Neuroscience" approach, grounded in the use of standardized methods across multiple types of brain data in a single platform, with over a million datasets. He founded the Brain Resource Company that created the first standardized international database on the human brain (over 300 publications). The database is the asset which shapes the development of MyBrainSolutions.com and TotalBrain.com for brain health and peak performance, used in Wellness Programs in more than 30 Fortune 500 Companies and more than 600,000 employees (including Boeing, AARP, Cerner). The first genetics test using this methodology (in 1700 patients) for treatment prediction in depression, is currently being completed for potential use in clinical practice.